Epstein Secrets

imes.corn/2020/11/24/world/sputnik-vaccine-russia.html> (11124, Kramer, 18.61M) reports the manufacturers of the "leading Russian vaccine candidate" Sputnik V "said on Tuesday that it showed an efficacy rate of 95 percent in preliminary results from a clinical trial, which would put it at the same level

rted the decision was Trump's and the access to the PDB could have been granted before the GSA administrator made the transition official Monday." The Washington Examiner <https://www.washingtonexaminer.corn/news/biden-to-begin-receiving-presidential- daily-briefings-as-transition-moves-forward> (11/24, Dunleavy, 448K)

of the first vaccines to the blockaded coastal area." Initially, "former health ministers and several medical workers were inoculated with Russia's Sputnik V jabs in front of dozens of cameras." Next, "medical workers and patients with chronic diseases are to start receiving injections on Tuesday." The

I have no reason to think that was not the correct decision,' Garland said, adding that he does `have to have an opportunity to talk with' Durham." The Washington Examiner (2/22, Dunleavy, 888K) reports that Grassley "asked Garland if he was saying that Durham would only be removed 'for cause.' Garland didn't commit to

the announcement "came shortly after news emerged that he would speak with Russian President Vladimir Putin on Monday about obtaining doses of the Sputnik V COVID-19 vaccine." The AP adds, "Other Latin American leaders who have tested positive for the coronavirus are Brazil's President Jair Bolsonaro,

onditions 'below that of impoverished persons living in third world countries." Sen. Grassley Asks DO) For Answers On Closing Flynn Investigation. The Washington Examiner (1/22, Dunleavy, 888K) reports that Sen. Chuck Grassley (R-IA) is calling on DO) "to provide answers about the reported ending of an investigation i

tgoing Trump Administration." While the New York Times (11/24, Kramer, 18.61M) reports the manufacturers of the "leading Russian vaccine candidate" Sputnik V "said on Tuesday that it showed an efficacy rate of 95 percent in preliminary results from a clinical trial, which would put it at the same level

orted the decision was Trump's and the access to the PDB could have been granted before the GSA administrator made the transition official Monday." The Washington Examiner (11/24, Dunleavy, 448K) reports that as "a major-party candidate, Biden had been receiving periodic intelligence briefings, but he had not yet been

uced Batch Of Sputnik V. Reuters (5/20) reports that Brazilian pharmaceutical company Uniao Quimica "completed production of its first batch of the Sputnik V coronavirus vaccine with active ingredients and technology supplied by Russia." Russia's Gamaleya Institute "said it had seen to quality control

all said, "CNA followed all laws, regulations, and published guidance, including OFAC's 2020 ransomware guidance, in its handling of this matter." The Washington Examiner (5/20, Krishan, 888K) also reports. Regulators Looking At Cryptocurrency Oversight, Transaction Reporting. Reuters (5/20, Lawder, Schneider) report

and its Berlin-based subsidiary, issued a joint press release saying the technology transfer will begin immediately. It expects the roll out of the Sputnik V vaccine in the third quarter of 2021." US Sanctions Exacerbate Pandemic In Iran. The AP (4/22, Karimi, Batrawy) reports that "as Iran faces what

filiate al-Shabaab and the local ISIS affiliate." COUNTER-INTELLIGENCE Michigan Woman Convicted In Tennessee Of Stealing Trade Secrets For China. The Washington Examiner (4/22, Dunleavy, 888K) reports, "A Chinese-born, naturalized U.S. citizen was convicted Thursday of stealing trade secrets worth up to $120 million